N/A
N=240
Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions
Breast Cancer Screening · Colon Cancer Screening · Prostate Cancer Screening
Bottom Line
View on ClinicalTrials.gov: NCT04601272 ↗Enrolled (actual)
240
Serious AEs
0.0%
Results posted
Mar 2023
Primary outcome: Primary: Shared Decision Making Process Measure — 1.05; 1.20; 2.10 score on a scale
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Decision aid (Behavioral)
- Age
- Adult, Older Adult · 35+ yrs
- Sex
- All
- Sponsor
- Massachusetts General Hospital
- Primary completion
- Apr 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Shared Decision Making Process Measure |
1.05; 1.20; 2.10 | — |
| SECONDARY The 9-item Shared Decision Making Questionnaire |
50.5; 56.8; 63.8 | — |
| SECONDARY Decisional Conflict Tool (SURE) |
49; 51; 67 | — |
| SECONDARY Single-Item Measure of Decision Regret |
33; 44; 33; 27; 32; 32 | — |
| SECONDARY Treatment Choice |
39; NA; NA; 8; NA; NA | — |
| SECONDARY Adapted Controlled Preference Scale |
33; 33; 45; 10; 19; 5 | — |
| SECONDARY Knowledge |
43; 58; 62 | — |
Summary
The purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a decision aid about the decision to screen or not screen for breast cancer, colon cancer, prostate cancer, or lung cancer.
Eligibility Criteria
Inclusion Criteria
Breast Cancer group
- Female sex
- Between ages of 35-55
- No previous diagnosis of breast cancer
Colon Cancer Group
- Between ages of 45-75
- No previous diagnosis of colon cancer
Prostate Cancer Group
- Male sex
- Between ages of 45-74
- No previous diagnosis of prostate cancer
Lung Cancer Group
- Between ages of 50-80
- No previous diagnosis of lung cancer
Exclusion Criteria
Breast Cancer group
- Unable to confirm primary language is English
- History of breast cancer
- Severe cognitive impairment who cannot consent for themselves
Colon Cancer Group
- Unable to confirm primary language is English
- History of colon cancer
- Severe cognitive impairment who cannot consent for themselves
Prostate Cancer Group
- Unable to confirm primary language is English
- History of prostate cancer
- Severe cognitive impairment who cannot consent for themselves
Lung Cancer Group
- Unable to confirm primary language is English
- History of lung cancer
- Severe cognitive impairment who cannot consent for themselves
Data sourced from ClinicalTrials.gov (NCT04601272). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.